We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment of Primary Menstrual Pain With Kanion Capsule

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00523146
First Posted: August 31, 2007
Last Update Posted: February 3, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Lianyungang Kanion Group, Ltd.
  Purpose

The objectives of this clinical trial are:

  • To further study the safety of Kanion Capsule (GF) in primary dysmenorrhea subjects;
  • To further evaluate the efficacy of GF in treatment of primary dysmenorrhea.

Condition Intervention Phase
Primary Dysmenorrhea Drug: Kanion Capsule Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Treatment of Primary Dysmenorrhea With Kanion Capsule (GF) A Randomized, Double-blind, Placebo-controlled, Repeated-Dose and Multi-Center Clinical Phase II Trial

Resource links provided by NLM:


Further study details as provided by Lianyungang Kanion Group, Ltd.:

Primary Outcome Measures:
  • pain reduction [ Time Frame: 6 months ]

Secondary Outcome Measures:
  • accompanying symptoms improvement [ Time Frame: 6 months ]

Study Start Date: April 2007
Study Completion Date: February 2009
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • primary dysmenorrhea

Exclusion Criteria:

  • secondary dysmenorrhea
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00523146


Locations
United States, Georgia
Mount Vernon Clinical Research, LLC
Sandy Springs, Georgia, United States, 30328
Sponsors and Collaborators
Lianyungang Kanion Group, Ltd.
Investigators
Study Chair: Jun Shao, Ph.D. Biokey Inc.
  More Information

ClinicalTrials.gov Identifier: NCT00523146     History of Changes
Other Study ID Numbers: GF-2006-001
First Submitted: August 29, 2007
First Posted: August 31, 2007
Last Update Posted: February 3, 2010
Last Verified: February 2010

Keywords provided by Lianyungang Kanion Group, Ltd.:
primary dysmenorrhea
Herbal remedy

Additional relevant MeSH terms:
Dysmenorrhea
Menstruation Disturbances
Pathologic Processes
Pelvic Pain
Pain
Neurologic Manifestations
Signs and Symptoms